141 related articles for article (PubMed ID: 3886398)
1. Aldosterone and prolactin responsiveness after prolonged treatment of congestive heart failure with captopril.
Jungmann E; Störger H; Althoff PH; Hadler D; Fassbinder W; Bussmann WD; Kaltenbach M; Schöffling K
Eur J Clin Pharmacol; 1985; 28(1):1-4. PubMed ID: 3886398
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic and hormonal responses during captopril therapy for heart failure: acute, chronic and withdrawal studies.
Nicholls MG; Ikram H; Espiner EA; Maslowski AH; Scandrett MS; Penman T
Am J Cardiol; 1982 Apr; 49(6):1497-501. PubMed ID: 6803564
[TBL] [Abstract][Full Text] [Related]
3. Effects of captopril on arterial and venous pressure, renal function, and humoral factors in severe chronic congestive heart failure.
Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T
Clin Pharmacol Ther; 1984 Oct; 36(4):456-63. PubMed ID: 6206977
[TBL] [Abstract][Full Text] [Related]
4. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
Kluger J; Cody RJ; Laragh JH
Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
[TBL] [Abstract][Full Text] [Related]
5. [Effect of captopril on the plasma aldosterone response to metoclopramide in normal subjects].
Zachariéva S; Koev D; Tcharaktchiev D; Moskov M; Andonova K
Ann Endocrinol (Paris); 1989; 50(3):233-6. PubMed ID: 2683976
[TBL] [Abstract][Full Text] [Related]
6. Short and long-term effects of treatment with low dose captopril in patients with severe congestive heart failure.
Dahlström U; Karlberg BE
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):231S-235S. PubMed ID: 6753905
[TBL] [Abstract][Full Text] [Related]
7. Effect of captopril on congestive heart failure.
Nishida M; Matsuo H; Sano H; Obata H; Yasuda H
Jpn Circ J; 1990 Dec; 54(12):1497-502. PubMed ID: 2077146
[TBL] [Abstract][Full Text] [Related]
8. The renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. Effect of angiotensin I converting enzyme inhibitor SQ 14225 (Captopril).
Kubo S; Nishioka A; Nishimura H; Sonotani N; Takatsu T
Jpn Circ J; 1980 Jun; 44(6):427-37. PubMed ID: 6995635
[No Abstract] [Full Text] [Related]
9. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA
Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension.
Muiesan G; Alicandri CL; Agabiti-Rosei E; Fariello R; Beschi M; Boni E; Castellano M; Moniti E; Muiesan L; Romanelli G; Zanielli A
Am J Cardiol; 1982 Apr; 49(6):1420-4. PubMed ID: 6280474
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II is more potent than potassium in regulating aldosterone in cardiac failure: evidence during captopril therapy.
Nicholls MG; Espiner EA; Ikram H; Maslowski AH; Lun S; Scandrett MS
J Clin Endocrinol Metab; 1981 Jun; 52(6):1253-6. PubMed ID: 7014601
[TBL] [Abstract][Full Text] [Related]
12. Long-term control of congestive heart failure with captopril.
Fouad FM; Tarazi RC; Bravo EL; Hart NJ; Castle LW; Salcedo EE
Am J Cardiol; 1982 Apr; 49(6):1489-96. PubMed ID: 6803563
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment of congestive heart failure with captopril.
Komajda M; Eugene M; Evans J; Drobinski G; Laurenceau JL; Grosgogeat Y
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):223S-229S. PubMed ID: 6753904
[TBL] [Abstract][Full Text] [Related]
14. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
Turini GA; Waeber B; Brunner HR
Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
[TBL] [Abstract][Full Text] [Related]
15. [The effects of dexamethasone and captopril on plasma aldosterone response to exogenous angiotensin II in normal men (author's transl)].
Mizuno K; Gotoh M; Haruyama K; Yamazaki M; Shigetomi S; Matsui J; Fukuchi S
Nihon Naibunpi Gakkai Zasshi; 1981 Aug; 57(8):1109-17. PubMed ID: 7032984
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
[TBL] [Abstract][Full Text] [Related]
17. Circadian rhythm of plasma aldosterone and time dependent alterations of aldosterone regulators.
Takeda R; Miyamori I; Ikeda M; Koshida H; Takeda Y; Yasuhara S; Morise T; Takimoto H
J Steroid Biochem; 1984 Jan; 20(1):321-3. PubMed ID: 6323866
[TBL] [Abstract][Full Text] [Related]
18. Contribution of the renin-angiotensin-aldosterone system to development of tolerance and fluid retention in chronic congestive heart failure during prazosin treatment.
Riegger GA; Haeske W; Kraus C; Kromer EP; Kochsiek K
Am J Cardiol; 1987 Apr; 59(8):906-10. PubMed ID: 3548307
[TBL] [Abstract][Full Text] [Related]
19. Captopril versus digoxin in mild-moderate chronic heart failure: a crossover study.
Alicandri C; Fariello R; Boni E; Zaninelli A; Castellano M; Beschi M; Agabiti Rosei E; Muiesan G
J Cardiovasc Pharmacol; 1987; 9 Suppl 2():S61-7. PubMed ID: 2441203
[TBL] [Abstract][Full Text] [Related]
20. Endocrine and cardiovascular influences of converting enzyme inhibition with SQ 14225 in hypertensive patients in the supine position and during head-up tilt before and after sodium depletion.
Morganti JA; Pickering TG; Lopez-Ovejero JA; Laragh JH
J Clin Endocrinol Metab; 1980 Apr; 50(4):748-54. PubMed ID: 6245101
[No Abstract] [Full Text] [Related]
[Next] [New Search]
